RT Journal Article
SR Electronic
T1 Aging metrics incorporating cognitive and physical function capture mortality risk: results from three prospective cohort studies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.14.21257213
DO 10.1101/2021.05.14.21257213
A1 Cao, Xingqi
A1 Chen, Chen
A1 Zhang, Jingyun
A1 Xue, Qian-Li
A1 Hoogendijk, Emiel O.
A1 Liu, Xiaoting
A1 Li, Shujuan
A1 Wang, Xiaofeng
A1 Zhu, Yiming
A1 Liu, Zuyun
YR 2021
UL http://medrxiv.org/content/early/2021/05/14/2021.05.14.21257213.abstract
AB Background The aims of this study were to: 1) describe the proportions of vulnerable persons identified by three existing aging metrics that incorporate cognitive and physical function; 2) examine the associations of the three metrics with mortality; and 3) develop and validate a new simple functional score for mortality prediction.Methods The three aging metrics were the combined presence of cognitive impairment and physical frailty (CI-PF), the frailty index (FI), and the motoric cognitive risk syndrome (MCR). We operationalized them with data from two large cohort studies: the China Health and Retirement Longitudinal Study (CHARLS) and the US National Health and Nutrition Examination Survey (NHANES). Logistic regression models or Cox proportional hazard regression models, and receiver operating characteristic curves were used to examine the associations of the three metrics with mortality. A new functional score was developed and validated in the Rugao Ageing Study (RAS), an independent dataset.Results In CHARLS, the proportions of vulnerable persons identified by CI-PF, FI, and MCR were 2.2%, 16.6%, and 19.6%, respectively. Each metric predicted mortality after adjustment for age and sex, with some variations in the strength of the associations (CI-PF, odds ratio (OR)=2.87, 95% confidence interval (CI)=1.74, 4.74; FI, OR=1.94, 95% CI=1.50, 2.50; MCR, OR=1.27, 95% CI=1.00, 1.62). CI-PF and FI had additional predictive utility beyond age and sex, as demonstrated by integrated discrimination improvement, and continuous net reclassification improvement (all P <0.001). These results were replicated in NHANES. Furthermore, we developed a new functional score by selecting six self-reported items from CI-PF and FI in CHARLS, and demonstrated that it predicted mortality risk. This functional score was further validated in RAS. To facilitate the quick screening of persons with deteriorations in cognitive and physical function, we introduced a publicly available online tool designed for this new functional score.Conclusions Despite the inherent differences in the aging metrics incorporating cognitive and physical function, they consistently capture mortality risk. The findings support the incorporation of cognitive and physical function for risk stratification in both Chinese and US persons, but call for caution when applying them in specific study settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the 2020 Irma and Paul Milstein Program for Senior Health project award (Milstein Medical Asian American Partnership Foundation), the Fundamental Research Funds for the Central Universities, and a project of National Nature Science Foundation of China (72004201). The current study was conducted at the School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine. The funders had no role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The CHARLS was approved by the Biomedical Ethics Review Committee of Peking University,the NHANES was approved by the National Center for Health Statistics Research Ethics Review Board, and the RAS was approved by the Human Ethics Committee of the School of Life Science at Fudan University. All persons provided informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe CHARLS data are publicly available through the CHARLS website at http://charls.pku.edu.cn/en. The NHANES data are available for sharing within the scientific community. Researchers can apply for data access at https://www.cdc.gov/nchs/nhanes/index.htm. The RAS data are available on request from the corresponding authors (XW and ZL). http://charls.pku.edu.cn/en https://www.cdc.gov/nchs/nhanes/index.htm